Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06685211

Electrical Stimulation for Vision Neuroenhancement in Glaucoma

Led by Stanford University · Updated on 2025-11-04

30

Participants Needed

1

Research Sites

128 weeks

Total Duration

On this page

Sponsors

S

Stanford University

Lead Sponsor

E

EYETRONIC, Inc

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of the study is to evaluate the efficacy, transorbital alternating current stimulation (rtACS) using the EYETRONIC for the treatment in patients with glaucoma.

CONDITIONS

Official Title

Electrical Stimulation for Vision Neuroenhancement in Glaucoma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant must be at least 18 years old
  • Participant must be able to follow study requirements and complete all scheduled activities
  • Participant must have primary open-angle glaucoma with mean deviation between -6 and -20 on reliable visual field testing
  • Participant's eye pressure must be stable and below 18 mmHg
  • If both eyes qualify, the worse eye or patient-preferred eye will be included
  • Participant must understand and sign informed consent, with assistance if vision is impaired
Not Eligible

You will not qualify if you...

  • Participant cannot comply with study procedures or follow-up visits
  • History of ocular herpes zoster
  • Requirement for acyclovir or related medications during the study
  • Corneal opacification or lack of clear optics
  • Uveitis or other ocular inflammatory diseases
  • Use of systemic steroids or immunosuppressive drugs
  • Participation in another drug clinical trial within the past 3 months
  • Pregnant or lactating
  • Any physical or mental condition increasing study risk or interfering with assessments
  • History of skull surgery, brain or heart pacemaker
  • Implanted intracranial metals or devices
  • Skin damage where electrodes are placed
  • Children or comatose patients
  • Recent epileptic seizure
  • Uncontrolled high blood pressure (≥160 mmHg) or intraocular pressure (≥27 mmHg)
  • Drug or alcohol abuse

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Byers Eye Institute at Stanford University

Palo Alto, California, United States, 94303

Actively Recruiting

Loading map...

Research Team

S

Study Team

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here